Supplementary Figure 5. Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort
figureposted on 20.05.2021, 08:28 by Jean-Philippe Metges, Dominique Genet, David Tougeron, Catherine Ligeza, Michel Ducreux, Christophe Borg, Rosine Guimbaud, Jean-Marc Phelip, Louis-Marie Dourthe, Stefano Kim
Supplementary Figure 5. Overall survival (a) and progression-free survival (b), stratified by prior anti-EGFR therapy.